Topic:Nanoparticles
Nanoparticles are ultrafine particles with dimensions measured in nanometers, utilized in various applications due to their unique properties. In equine research, nanoparticles are investigated for their potential in drug delivery, imaging, and disease treatment. Their small size allows for enhanced penetration and distribution in biological systems, offering possibilities for targeted therapies and improved diagnostic techniques. Studies focus on the synthesis, characterization, and biocompatibility of nanoparticles in horses, as well as their effects on equine physiology and health. This page compiles peer-reviewed research studies and scholarly articles that explore the applications, safety, and impact of nanoparticles in equine medicine.
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles. Strangles is a bacterial infection of the Equidae family that affects the nasopharynx and draining lymph nodes, caused by Streptococcus equi subspecies equi. This agent is responsible for 30% of all worldwide equine infections and is quite sensitive to penicillin and other antibiotics. However, prevention is still the best option because the current antibiotic therapy and vaccination is often ineffective. As S. equi induces very strong systemic and mucosal responses in convalescent horses, an effective and economic strangles vaccine is still a priority. In this study the humoral, cellular and ...